Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 12 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bladder instillation WITH triamcinolone acetonide | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬1. Bladder instillation WITH triamcinolone acetonide
| [1] NR3C1 NR3C1 💬1. Bladder instillation WITH triamcinolone acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 226 226 💬1. Bladder instillation WITH triamcinolone acetonide
| ||||||||||||||||||||||||||||
| 2 | Bladder instillation WITHOUT triamcinolone acetonide | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬2. Bladder instillation WITHOUT triamcinolone acetonide
| [1] NR3C1 NR3C1 💬2. Bladder instillation WITHOUT triamcinolone acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 226 226 💬2. Bladder instillation WITHOUT triamcinolone acetonide
| ||||||||||||||||||||||||||||
| 3 | Bupivacaine, triamcinolone, and heparin (BTH) | [3] Bupivacaine Bupivacaine,Heparin, Triamcinolone | [3] Triamcinolone
Triamcinolone
,Adomiparin , Bupivacaine 💬 3. Bupivacaine, triamcinolone, and heparin (BTH)
| [7] NR3C1 NR3C1,SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 3. Bupivacaine, triamcinolone, and heparin (BTH)
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬 [5] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synaps ... | [1] 226 226 💬3. Bupivacaine, triamcinolone, and heparin (BTH)
| ||||||||||||||||||||||||||||
| 4 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP Large dose of prednisolone plus intra-lesional of TriamcinoloneAcetonide followed the systemic combi ... | [5] Dapsone Dapsone,Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone | [5] Triamcinolone
Triamcinolone
,Prednisolone , Dapsone , Mycophenolate mofetil , Mycophenolic acid 💬 [5] Triamcinolone , Prednisolone , Dapsone , Mycophenolate mofetil , Mycophenolic acid 💬 ... 4. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| [3] IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 4. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 [5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nu ... | [1] 162 162 💬4. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| ||||||||||||||||||||||||||||
| 5 | Triamcinolone | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬5. Triamcinolone
| [1] NR3C1 NR3C1 💬5. Triamcinolone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [11] 35 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬
| ||||||||||||||||||||||||||||
| 6 | Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬6. Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)
| [1] NR3C1 NR3C1 💬6. Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬6. Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)
| ||||||||||||||||||||||||||||
| 7 | Triamcinolone Acetonide | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬7. Triamcinolone Acetonide
| [1] NR3C1 NR3C1 💬7. Triamcinolone Acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 35 35, 46, 56 💬
| ||||||||||||||||||||||||||||
| 8 | Triamcinolone Acetonide and normal saline solution | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬8. Triamcinolone Acetonide and normal saline solution
| [1] NR3C1 NR3C1 💬8. Triamcinolone Acetonide and normal saline solution
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬8. Triamcinolone Acetonide and normal saline solution
| ||||||||||||||||||||||||||||
| 9 | Triamcinolone hexacetonid (Lederspan) | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬9. Triamcinolone hexacetonid (Lederspan)
| [1] NR3C1 NR3C1 💬9. Triamcinolone hexacetonid (Lederspan)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬9. Triamcinolone hexacetonid (Lederspan)
| ||||||||||||||||||||||||||||
| 10 | Triamcinolone hexacetonide | [1] Triamcinolone Triamcinolone | [1] Triamcinolone
Triamcinolone
💬10. Triamcinolone hexacetonide
| [1] NR3C1 NR3C1 💬10. Triamcinolone hexacetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 107 💬
|